IRADIMED CORP - Common Stock (IRMD)

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Equity / Common Stock
Shares outstanding
12,733,410
Total 13F shares
1,372,532
Share change
+1,372,532
Total reported value
$9,620,000
Price per share
$7.01
Number of holders
16
Value change
+$9,620,000
Number of buys
16

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) as of Q3 2014

As of 30 Sep 2014, IRADIMED CORP - Common Stock (IRMD) was held by 16 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,372,532 shares. The largest 10 holders included Broadfin Capital, LLC, SOPHROSYNE CAPITAL LLC, MARXE AUSTIN W & GREENHOUSE DAVID M, WASATCH ADVISORS INC, GRUBER & MCBAINE CAPITAL MANAGEMENT LLC, ROYCE & ASSOCIATES LLC, GOLDMAN SACHS GROUP INC, Manatuck Hill Partners, LLC, CONNORS INVESTOR SERVICES INC, and PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C.. This page lists 16 institutional shareholders reporting positions in this security for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.